No red flags identified.
AI Transparency Report
Jack And Jill Late Stage Cancerfoundation Inc demonstrates consistent financial activity, with revenues generally exceeding expenses in recent years, contributing to a steady growth in assets. For instance, in 2022, revenue was $1,449,888 against expenses of $1,153,661, leading to an increase in assets to $1,791,868. The organization's liabilities have consistently been very low or zero across all reported periods, indicating strong financial management and minimal debt burden. This suggests a healthy balance sheet and responsible handling of funds.
The organization's transparency is notably high regarding executive compensation, as all filings indicate 0% officer compensation. This practice is commendable and suggests that resources are primarily directed towards program services and operational needs rather than high executive salaries. While specific program, administrative, and fundraising expense breakdowns are not provided in the summary data, the overall financial health and lack of officer compensation are positive indicators of fiscal responsibility. The consistent growth in assets over the past decade, from $238,220 in 2015 to $1,787,578 in 2023, further underscores its financial stability and ability to build reserves.